在整个COVID大流行期间,抗病毒临床试验设计:不断变化的终点和经验教训
Beatrice Z Sim1,2,3, Andre C Kalil4, Cameron R Wolfe1
1Division of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina, USA.
Current opinion in infectious diseases
|November 28, 2025
概括
由于不确定性,临床试验设计在COVID-19大流行期间面临挑战. 适应性,平台和主协议被用于解决不断变化的疾病和病毒景观.
科学领域:
- 传染病流行病学 传染病流行病学
- 临床试验方法论 临床试验方法论
- 流行病的准备情况.
背景情况:
- 随着COVID-19的流行,临床试验设计面临了前所未有的挑战.
- 关于病毒的自然史,风险人群和最佳护理的不确定性影响了研究.
- 现有的试验框架需要适应,以应对不断变化的流行病环境.
研究的目的:
- 审查和分析在COVID-19大流行期间使用的试验设计.
- 解决在重大科学和医疗保健系统不确定性中进行研究的复杂性.
- 评估在传染病研究中保持科学严谨性和实用性的策略.
主要方法:
- 对适应性试验设计的审查.
- 对平台试验方法的分析.
- 对总协议框架的检查.
- 讨论与每个设计相关的优势和挑战.
主要成果:
- 适应性试验设计在应对不断变化的数据时提供了灵活性.
- 平台试验使得同时对多种干预措施的有效评估成为可能.
- 主协议简化了执行多项相关研究的流程.
- 每个设计类型都面临着独特的后勤和运营挑战.
结论:
- 未来的流行病需要适应性和强大的临床试验设计.
- 将不断发展的科学理解与实践试验执行相结合仍然是一个关键的挑战.
- 创新的试验方法对于有效的流行病应对和未来的准备工作至关重要.
相关概念视频
Study Designs in Epidemiology
850
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
850
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
382
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
382
Bioavailability Study Design: Healthy Subjects Versus Patients
135
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
135
Dosage Regimens: Designs and Approaches
242
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
242


